This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Boryung Pharmaceutical Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Jung-Bok Lee: Innovator in Pyrimidinone Compounds
Introduction
Jung-Bok Lee is a notable inventor based in Gyunggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address cardiovascular diseases. His innovative approach has led to advancements in the preparation of pyrimidinone compounds.
Latest Patents
Jung-Bok Lee holds a patent for a "Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof." This process enables the efficient production of pyrimidinone derivatives in high yields. These compounds are particularly useful for treating cardiovascular diseases by antagonizing the activity of angiotensin II receptors.
Career Highlights
Lee is associated with Boryung Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical development. His work has been instrumental in creating effective treatments for serious health conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Some of his notable coworkers include Sang-Lin Kim and Ji-han Kim, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Jung-Bok Lee's contributions to the field of pharmaceuticals, particularly through his innovative methods for preparing pyrimidinone compounds, highlight his role as a key inventor in the industry. His work continues to impact the treatment of cardiovascular diseases positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile